MRI-based classification of IDH mutation and 1p/19q codeletion status of gliomas using a 2.5D hybrid multi-task convolutional neural network

• URL: http://arxiv.org/abs/2210.03779v1
• Date: Fri, 7 Oct 2022 18:46:39 GMT
• Title: MRI-based classification of IDH mutation and 1p/19q codeletion status of gliomas using a 2.5D hybrid multi-task convolutional neural network
• Authors: Satrajit Chakrabarty, Pamela LaMontagne, Joshua Shimony, Daniel S. Marcus, Aristeidis Sotiras
• Abstract summary: Isocitrate dehydrogenase mutation and 1p/19q codeletion status are important prognostic markers for glioma. Our goal was to develop artificial intelligence-based methods to non-invasively determine these molecular alterations from MRI. A 2.5D hybrid convolutional neural network was proposed to simultaneously localize the tumor and classify its molecular status.
• Score: 0.18374319565577152
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status are important prognostic markers for glioma. Currently, they are determined using invasive procedures. Our goal was to develop artificial intelligence-based methods to non-invasively determine these molecular alterations from MRI. For this purpose, pre-operative MRI scans of 2648 patients with gliomas (grade II-IV) were collected from Washington University School of Medicine (WUSM; n = 835) and publicly available datasets viz. Brain Tumor Segmentation (BraTS; n = 378), LGG 1p/19q (n = 159), Ivy Glioblastoma Atlas Project (Ivy GAP; n = 41), The Cancer Genome Atlas (TCGA; n = 461), and the Erasmus Glioma Database (EGD; n = 774). A 2.5D hybrid convolutional neural network was proposed to simultaneously localize the tumor and classify its molecular status by leveraging imaging features from MR scans and prior knowledge features from clinical records and tumor location. The models were tested on one internal (TCGA) and two external (WUSM and EGD) test sets. For IDH, the best-performing model achieved areas under the receiver operating characteristic (AUROC) of 0.925, 0.874, 0.933 and areas under the precision-recall curves (AUPRC) of 0.899, 0.702, 0.853 on the internal, WUSM, and EGD test sets, respectively. For 1p/19q, the best model achieved AUROCs of 0.782, 0.754, 0.842, and AUPRCs of 0.588, 0.713, 0.782, on those three data-splits, respectively. The high accuracy of the model on unseen data showcases its generalization capabilities and suggests its potential to perform a 'virtual biopsy' for tailoring treatment planning and overall clinical management of gliomas.

Related papers

• Brain Tumor Classification on MRI in Light of Molecular Markers [61.77272414423481]
  Co-deletion of the 1p/19q gene is associated with clinical outcomes in low-grade gliomas. This study aims to utilize a specially MRI-based convolutional neural network for brain cancer detection.
  arXiv  Detail & Related papers  (2024-09-29T07:04:26Z)
• AXIAL: Attention-based eXplainability for Interpretable Alzheimer's Localized Diagnosis using 2D CNNs on 3D MRI brain scans [43.06293430764841]
  This study presents an innovative method for Alzheimer's disease diagnosis using 3D MRI designed to enhance the explainability of model decisions. Our approach adopts a soft attention mechanism, enabling 2D CNNs to extract volumetric representations. With voxel-level precision, our method identified which specific areas are being paid attention to, identifying these predominant brain regions.
  arXiv  Detail & Related papers  (2024-07-02T16:44:00Z)
• Analysis of the BraTS 2023 Intracranial Meningioma Segmentation Challenge [44.586530244472655]
  We describe the design and results from the BraTS 2023 Intracranial Meningioma Challenge. The BraTS Meningioma Challenge differed from prior BraTS Glioma challenges in that it focused on meningiomas. The top ranked team had a lesion-wise median dice similarity coefficient (DSC) of 0.976, 0.976, and 0.964 for enhancing tumor, tumor core, and whole tumor.
  arXiv  Detail & Related papers  (2024-05-16T03:23:57Z)
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging [59.79875531898648]
  DeepGlioma is an artificial-intelligence-based diagnostic screening system. DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy.
  arXiv  Detail & Related papers  (2023-03-23T18:50:18Z)
• Improving Deep Learning Models for Pediatric Low-Grade Glioma Tumors Molecular Subtype Identification Using 3D Probability Distributions of Tumor Location [0.0]
  CNN models for pLGG subtype identification rely on tumor segmentation. We propose to augment the CNN models using tumor location probability in MRI data. We achieved statistically significant improvements by incorporating tumor location into the CNN models.
  arXiv  Detail & Related papers  (2022-10-13T18:30:11Z)
• A New Deep Hybrid Boosted and Ensemble Learning-based Brain Tumor Analysis using MRI [0.28675177318965034]
  Two-phase deep learning-based framework is proposed to detect and categorize brain tumors in magnetic resonance images (MRIs) In the first phase, a novel deep boosted features and ensemble classifiers (DBF-EC) scheme is proposed to detect tumor MRI images from healthy individuals effectively. In the second phase, a new hybrid features fusion-based brain tumor classification approach is proposed, comprised of dynamic-static feature and ML classifier to categorize different tumor types.
  arXiv  Detail & Related papers  (2022-01-14T10:24:47Z)
• Comparison of Machine Learning Classifiers to Predict Patient Survival and Genetics of GBM: Towards a Standardized Model for Clinical Implementation [44.02622933605018]
  Radiomic models have been shown to outperform clinical data for outcome prediction in glioblastoma (GBM) We aimed to compare nine machine learning classifiers to predict overall survival (OS), isocitrate dehydrogenase (IDH) mutation, O-6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation, epidermal growth factor receptor (EGFR) VII amplification and Ki-67 expression in GBM patients. xGB obtained maximum accuracy for OS (74.5%), AB for IDH mutation (88%), MGMT methylation (71,7%), Ki-67 expression (86,6%), and EGFR amplification (81,
  arXiv  Detail & Related papers  (2021-02-10T15:10:37Z)
• WHO 2016 subtyping and automated segmentation of glioma using multi-task deep learning [2.8881360490071786]
  We developed a single multi-task convolutional neural network that can predict the IDH mutation status, the 1p/19q co-deletion status, and the grade of a tumor. We tested our method on an independent dataset of 240 patients from 13 different institutes, and achieved an IDH-AUC of 0.90, 1p/19q-AUC of 0.85, grade-AUC of 0.81, and a mean whole tumor DICE score of 0.84.
  arXiv  Detail & Related papers  (2020-10-09T08:18:53Z)
• Deep Learning-based Computational Pathology Predicts Origins for Cancers of Unknown Primary [2.645435564532842]
  Cancer of unknown primary (CUP) is an enigmatic group of diagnoses where the primary anatomical site of tumor origin cannot be determined. Recent work has focused on using genomics and transcriptomics for identification of tumor origins. We present a deep learning-based computational pathology algorithm that can provide a differential diagnosis for CUP.
  arXiv  Detail & Related papers  (2020-06-24T17:59:36Z)
• Spatial-And-Context aware (SpACe) "virtual biopsy" radiogenomic maps to target tumor mutational status on structural MRI [0.7573687311514342]
  "virtual biopsy" maps that incorporate context-features from co-localized biopsy site along with spatial-priors from population atlases. SpACe maps obtained training and testing accuracies of 90% (n=71) and 90.48% (n=21) in identifying EGFR amplification status. SpACe maps could provide surgical navigation to improve localization of sampling sites for targeting of specific driver genes in cancer.
  arXiv  Detail & Related papers  (2020-06-17T13:57:59Z)
• Segmentation of the Myocardium on Late-Gadolinium Enhanced MRI based on 2.5 D Residual Squeeze and Excitation Deep Learning Model [55.09533240649176]
  The aim of this work is to develop an accurate automatic segmentation method based on deep learning models for the myocardial borders on LGE-MRI. A total number of 320 exams (with a mean number of 6 slices per exam) were used for training and 28 exams used for testing. The performance analysis of the proposed ensemble model in the basal and middle slices was similar as compared to intra-observer study and slightly lower at apical slices.
  arXiv  Detail & Related papers  (2020-05-27T20:44:38Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.